NCT Number: NCT04030559
Phase: Phase 2
Trial Summary: This phase II trial studies how well niraparib, when given before surgery, works in treating patients with high risk prostate cancer that has not spread to other parts of the body – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s):
Acronym:
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives